AgingResearch.News
Journal of Clinical Lipidology

The addition of evolocumab vs ezetimibe to statin therapy for coronary plaque regression and sd-LDL reduction in patients with ultrahigh-risk ASCVD

By Xiaoping Li, Lin Yang, Xiao Zhou, Show 2 more authorsYanxia Liu
Trial in peopleInterventions
Paper

The paper

Xiaoping Li, Lin Yang, Xiao Zhou, Show 2 more authorsYanxia Liu

Dalian Medical University; Chinese People's Liberation Army

Journal of Clinical Lipidology, 7 Aug 2026

doi.org/10.1016/j.jacl.2026.07.040PubMed 42624727

Related